Flexeril and Verapamil hcl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Verapamil hcl (verapamil hydrochloride). Common drug interactions include haemoglobin decreased among females and asthma among males.
The phase IV clinical study analyzes what interactions people have when they take Flexeril and Verapamil hcl. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.
What is Verapamil hcl?
Verapamil hcl has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,807 Verapamil hcl users. Check the latest studies of Verapamil hcl.
34 people who take Flexeril and Verapamil hcl together, and have interactions are studied.

What are the common drug interactions of Flexeril and Verapamil Hcl, by gender? *:
female:
- Haemoglobin decreased
- Hallucination (an experience involving the perception of something not present)
- Hyperhidrosis (abnormally increased sweating)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Injection site erythema (redness at injection site)
- Joint range of motion decreased (disease of joint movement)
- Joint stiffness
- Ligament sprain (ligament stretched)
- Malaise (a feeling of general discomfort or uneasiness)
- Melaena (the passage of black, tarry stools)
male:
- Asthma
- Cataract (clouding of the lens inside the eye)
- Increased viscosity of bronchial secretion
- Insomnia (sleeplessness)
- Joint swelling
- Lacrimation increased
- Multiple allergies (allergy to multiple agents)
- Peripheral swelling
- Productive cough
- Respiratory disorder (respiratory disease)
What are the common drug interactions of Flexeril and Verapamil Hcl, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Vaginal haemorrhage (vaginal bleeding)
40-49:
- Enthesopathy (disorder of entheses (bone attachments))
- Essential hypertension (primary hypertension)
- Eustachian tube disorder (inflammation of the middle ear, commonly affects the eustachian tube)
- Gastritis (inflammation of stomach)
- Gastroduodenitis (an inflammation of the mucous membrane of the stomach and duodenum)
- Gastroenteritis (inflammation of stomach and intestine)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Generalised anxiety disorder (excessive, uncontrollable, unexplained and often irrational worry)
- Haematuria (presence of blood in urine)
- Hypoglycaemia (deficiency of glucose in the bloodstream)
50-59:
- Drug hypersensitivity
- Drug ineffective
- Fatigue (feeling of tiredness)
- Joint swelling
- Arthralgia (joint pain)
- Asthma
- Burning sensation
- Cough
- Disability
- Drug administration error
60+:
- Cardiac arrest
- Aortic stenosis (obstruction to the outflow of blood from the left ventricle into the aorta)
- Alopecia (absence of hair from areas of the body)
- Anaemia (lack of blood)
- Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
- Atrophy (wasting away of a part of the body)
- Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
- Calcinosis (calcium deposits in any soft tissue)
- Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
- Chest pain
What are the existing conditions these people have? *
- Back Pain: 5 people, 14.71%
- Depression: 5 people, 14.71%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 11.76%
- Intervertebral Disc Degeneration (spinal disc degeneration): 3 people, 8.82%
- Lipids Abnormal: 3 people, 8.82%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 8.82%
- Insomnia (sleeplessness): 3 people, 8.82%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 8.82%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 8.82%
- Oedema Peripheral (superficial swelling): 3 people, 8.82%
* Approximation only. Some reports may have incomplete information.
Do you take Flexeril and Verapamil hcl?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Flexeril (38,308 reports)
- Verapamil hcl (5,807 reports)
Browse all drug interactions of Flexeril and Verapamil hcl:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Verapamil hcl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Flexeril and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Verapamil hcl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and verapamil hydrochloride (the active ingredients of Flexeril and Verapamil hcl, respectively), and Flexeril and Verapamil hcl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Haldol and Coca - 3 seconds ago
- Drug interactions of Gabitril and Actonel - 4 seconds ago
- Could Acthar cause Irritability? - 6 seconds ago
- Drug interactions of Singulair and Austedo - 8 seconds ago
- Could Adcirca cause Irritability? - 10 seconds ago
- Peripheral Arterial Occlusive Disease and Heart Rate Increased - 12 seconds ago
- Could Absorica cause Irritability? - 13 seconds ago
- Could Adempas cause Irritability? - 14 seconds ago
- Could Altace cause Hypothyroidism? - 14 seconds ago
- Could Benicar cause Oral Pain? - 20 seconds ago